These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37751175)

  • 1. Astragaloside IV Inhibited Podocyte Pyroptosis in Diabetic Kidney Disease by Regulating SIRT6/HIF-1α Axis.
    Zhang M; Liu W; Liu Y; Zhang Z; Hu Y; Sun D; Li S; Fang J
    DNA Cell Biol; 2023 Oct; 42(10):594-607. PubMed ID: 37751175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirt6 ameliorates high glucose-induced podocyte cytoskeleton remodeling via the PI3K/AKT signaling pathway.
    Zhang Z; Huang H; Tao Y; Liu H; Fan Y
    Ren Fail; 2024 Dec; 46(2):2410396. PubMed ID: 39378103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-
    He J; Cui J; Shi Y; Wang T; Xin J; Li Y; Shan X; Zhu Z; Gao Y
    J Diabetes Res; 2023; 2023():7423661. PubMed ID: 37261217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
    Wang ZS; Xiong F; Xie XH; Chen D; Pan JH; Cheng L
    BMC Nephrol; 2015 Mar; 16():44. PubMed ID: 25886386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
    Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
    Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental Mesenchymal Stem Cells Alleviate Podocyte Injury in Diabetic Kidney Disease by Modulating Mitophagy via the SIRT1-PGC-1alpha-TFAM Pathway.
    Han X; Wang J; Li R; Huang M; Yue G; Guan L; Deng Y; Cai W; Xu J
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new strategy for Astragaloside IV in the treatment of diabetic kidney disease: Analyzing the regulation of ferroptosis and mitochondrial function of renal tubular epithelial cells.
    Liu J; Yang K; Zhou L; Deng J; Rong G; Shi L; Zhang X; Ren J; Zhang Y; Cao W
    Int Immunopharmacol; 2024 Nov; 141():112794. PubMed ID: 39137626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects and mechanisms of Supplemented Gegen Qinlian Decoction Formula against podocyte pyroptosis and insulin resistance in model rats with diabetic kidney disease].
    Wang MZ; Yue LJ; Wan YG; Huang H; Wu W; Tu Y; Liu BH; Fang QJ; Yuan CC; Wang J; Li H; Wan ZY
    Zhongguo Zhong Yao Za Zhi; 2021 Sep; 46(17):4471-4479. PubMed ID: 34581052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic and lipidomic analysis of the mechanism underlying astragaloside IV in mitigating ferroptosis through hypoxia-inducible factor 1α/heme oxygenase 1 pathway in renal tubular epithelial cells in diabetic kidney disease.
    Liu J; Ren J; Zhou L; Tan K; Du D; Xu L; Cao W; Zhang Y
    J Ethnopharmacol; 2024 Nov; 334():118517. PubMed ID: 38972525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astragaloside IV Alleviates Podocyte Injury in Diabetic Nephropathy through Regulating IRE-1α/NF-κ B/NLRP3 Pathway.
    Sun DL; Guo ZY; Liu WY; Zhang L; Zhang ZY; Hu YL; Li SF; Zhang MY; Zhang G; Wang JJ; Fang JA
    Chin J Integr Med; 2024 Jul; ():. PubMed ID: 39039342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragaloside IV/lncRNA-TUG1/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats.
    Lei X; Zhang L; Li Z; Ren J
    Drug Des Devel Ther; 2018; 12():2785-2793. PubMed ID: 30233141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hirudin Reduces the Expression of Markers of the Extracellular Matrix in Renal Tubular Epithelial Cells in a Rat Model of Diabetic Kidney Disease Through the Hypoxia-Inducible Factor-1α (HIF-1α)/Vascular Endothelial Growth Factor (VEGF) Signaling Pathway.
    Pang X; Zhang Y; Shi X; Peng Z; Xing Y; Jiarui H
    Med Sci Monit; 2020 May; 26():e921894. PubMed ID: 32473006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of PERK-ATF4-CHOP pathway by Astragaloside IV is associated with the inhibition of endoplasmic reticulum stress-induced podocyte apoptosis in diabetic rats.
    Chen Y; Gui D; Chen J; He D; Luo Y; Wang N
    Cell Physiol Biochem; 2014; 33(6):1975-87. PubMed ID: 25012492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic Analysis Reveals the Protection of Astragaloside IV against Diabetic Nephropathy by Modulating Inflammation.
    Zhang Y; Tao C; Xuan C; Jiang J; Cao W
    Oxid Med Cell Longev; 2020; 2020():9542165. PubMed ID: 32855769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rutaecarpine protects podocytes in diabetic kidney disease by targeting VEGFR2/NLRP3-mediated pyroptosis.
    Hu X; Wang J; Jiang L; Liu X; Ge Q; Wang Q; Qi X; Wu Y
    Int Immunopharmacol; 2024 Mar; 130():111790. PubMed ID: 38447417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects and mechanisms of total flavones of Abelmoschus manihot in improving insulin resistance and podocyte epithelial-mesenchymal transition in diabetic kidney disease based on IRS1/PI3K/Akt pathway].
    Wang Y; Cao DW; Wan YG; Mu GL; Wu W; Fang QJ; Li YJ; Cha SY; Tu Y; Wan ZY
    Zhongguo Zhong Yao Za Zhi; 2023 May; 48(10):2646-2656. PubMed ID: 37282926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Sirt6 promotes M2 macrophage transformation, alleviating renal injury in diabetic nephropathy.
    Ji L; Chen Y; Wang H; Zhang W; He L; Wu J; Liu Y
    Int J Oncol; 2019 Jul; 55(1):103-115. PubMed ID: 31115579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydroxyacetone phosphate accumulation leads to podocyte pyroptosis in diabetic kidney disease.
    Zhang Z; Hu H; Luo Q; Yang K; Zou Z; Shi M; Liang W
    J Cell Mol Med; 2024 Feb; 28(3):e18073. PubMed ID: 38063077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
    Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
    Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenylsulfate-induced oxidative stress and mitochondrial dysfunction in podocytes are ameliorated by Astragaloside IV activation of the SIRT1/PGC1α /Nrf1 signaling pathway.
    Li L; Zou J; Zhou M; Li H; Zhou T; Liu X; Huang Q; Yang S; Xiang Q; Yu R
    Biomed Pharmacother; 2024 Aug; 177():117008. PubMed ID: 38901196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.